Clinical trial
Apabetalone for Pulmonary Arterial Hypertension
NCT04915300
Study timeline
Study start (estimated)2023-10-01Date precision: month
Registry last updated2023-04-18
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Pulmonary Arterial Hypertensionunresolved
Interventions
ApabetaloneDRUG
PlaceboDRUG
Sponsors & collaborators
Laval Universitylead sponsor
Canadian Institutes of Health Research (CIHR)collaborator
Resverlogix Corpcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04915300 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.